Pavan Sharma

Never miss an opportunity with high impact economic event coverage, expert commentary, videos and more from our global market analysts.

6 February 2021 -

Very Healthy Numbers

6 February 2021 -

Fisher & Paykel Healthcare : FPH – NZX/ASX – Stunning Growth

’s initial recommendation on FPH was at $9.79 in 2016 which delivered a massive capital growth of 242.19% so far for our investors. The stock has been moving sideways and consolidating since September last year within the range of $37.00 to $31.00.

5 February 2021 -

Still See Opportunity

2 February 2021 -

Week Ahead | Climate Commission Report & Z Energy

it was probably easy to lose sight of the positive vaccine developments that took place over the past week. Over the weekend, the UK announced a huge day of vaccinations with 598k done in one day, almost 1% of the population

1 February 2021 -

Troubled times or a value buy?

1 February 2021 -

QBE – Troubled times or a Value BUY?

QBE is trading @ $8.03 and there is a strong support zone between $8.00 to $7.70. and we see that the stock prices can hold in this zone. After a consolidation and with support of future good news the trend can change and the stock prices could recover to

1 February 2021 -

Z Energy -a Re-opening Trade

We reiterate our BUY rating on this point for the investors who missed the opportunity previously. There is a strong support zone between $2.90 to $2.80. If this is broken the stock will move towards $2.50, which we see as unlikely. We see this support zo

30 January 2021 -

GameStop Stonking | Pushpay Update

Headlines are being dominated by electronics gaming retailer GameStop, which was up +92% overnight (and another +54% after hours) extending its surge as day traders continued to pile into the heavily shorted retailer.

30 January 2021 -

Markets Tumble, Fed Decision | Coca-Cola Amatil

Global markets tumbled overnight (in the worst session since October last year (S&P 500 index -2.6%) as investors took profits and turned cautious.